Section of Hygiene - Institute of Public Health, Università Cattolica del Sacro Cuore, Roma, Italia.
Unit of Biochemical Chemistry and Clinical Molecular Biology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italia.
PLoS One. 2020 Aug 6;15(8):e0237159. doi: 10.1371/journal.pone.0237159. eCollection 2020.
Computerized Clinical Decision Support Systems (CCDSS) have become increasingly important in ensuring patient safety and supporting all phases of clinical decision making. The aim of this study is to evaluate, through a CCDSS, the rate of the laboratory tests overuse and to estimate the cost of the inappropriate requests in a large university hospital.
In this observational study, hospital physicians submitted the examination requests for the inpatients through a Computerized Physician Order Entry. Violations of the rules in tests requests were intercepted and counted by a CCDSS, over a period of 20 months. Descriptive and inferential statistics (Student's t-test and ANOVA) were made. Finally, the monthly comprehensive cost of the laboratory tests was calculated.
During the observation period a total of 5,716,370 requests were analyzed and 809,245 violations were counted. The global rate of overuse was 14.2% ± 3.0%. The most inappropriate exams were Alpha Fetoprotein (85.8% ± 30.5%), Chlamydia trachomatis Nucleic Acid Amplification (48.7% ± 8.8%) and Alkaline Phosphatase (20.3% ± 6.5%). The monthly cost of over-utilization was 56,534€ for basic panel, 14,421€ for coagulation, 4,758€ for microbiology, 432€ for immunology exams. All the exams, generated an estimated avoidable cost of 1,719,337€ (85,967€ per month) for the hospital.
The study confirms the wide variability in over-utilization rates of laboratory tests. For these reasons, the real impact of inappropriateness is difficult to assess, but the generated costs for patients, hospitals and health systems are certainly high and not negligible. It would be desirable for international medical communities to produce a complete panel of prescriptive rules for all the most common laboratory exams that is useful not only to reduce costs, but also to ensure standardization and high-quality care.
计算机临床决策支持系统(CCDSS)在确保患者安全和支持临床决策的所有阶段方面变得越来越重要。本研究旨在通过 CCDSS 评估实验室检查过度使用的比率,并估计大型大学医院中不适当请求的成本。
在这项观察性研究中,医院医生通过计算机化医嘱录入系统提交住院患者的检查请求。CCDSS 拦截并计算了违反检查请求规则的次数,持续了 20 个月。进行了描述性和推断性统计分析(学生 t 检验和 ANOVA)。最后,计算了实验室检查的每月综合成本。
在观察期间,共分析了 5716370 份请求,共发现 809245 次违规。过度使用的总体比率为 14.2%±3.0%。最不适当的检查是甲胎蛋白(85.8%±30.5%)、沙眼衣原体核酸扩增(48.7%±8.8%)和碱性磷酸酶(20.3%±6.5%)。过度使用的每月费用为基础检测 56534 欧元,凝血检测 14421 欧元,微生物检测 4758 欧元,免疫检测 432 欧元。所有检查导致医院估计可避免的费用为 1719337 欧元(每月 85967 欧元)。
该研究证实了实验室检查过度使用率的广泛差异。由于这些原因,不适当的实际影响难以评估,但对患者、医院和卫生系统造成的成本肯定很高,不容忽视。国际医学界最好制定一套针对所有最常见实验室检查的规定性规则,这不仅有助于降低成本,还有助于确保标准化和高质量的护理。